CT
UTHR icon

Chicago Trust’s United Therapeutics UTHR Stock Holding History

Chicago Trust’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$578K Sell
1,066
-17
-2% -$9.57K 0.08% 226
2026
Q1 		$642K Hold
1,083
– – 0.1% 199
2025
Q4 		$528K Buy
1,083
+112
+12% +$52.2K 0.08% 229
2025
Q3 		$407K Buy
+971
New +$327K 0.06% 289
2025
Q1 		– Sell
-570
Closed -$201K – 380
2024
Q4 		$201K Hold
570
– – 0.04% 344
2024
Q3 		$204K Buy
+570
New +$193K 0.04% 362

Other funds holding UTHR

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
AIM
Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Chicago Trust's UTHR Position: Q2 2026 in Review

Chicago Trust reduced its United Therapeutics (UTHR) stake by 1.6% in Q2 2026, selling an estimated $9.57K and leaving 1,066 shares worth $578K. The position accounts for 0.08% of the portfolio, ranked #226.

Chicago Trust first reported a position in UTHR in Q3 2024 and has held it in 6 quarters since. The position peaked at $642K in Q1 2026. 107 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Chicago Trust held 1,066 shares of United Therapeutics worth $578K as of Q2 2026.
  • Chicago Trust sold 17 United Therapeutics shares in Q2 2026, an estimated $9.57K.
  • United Therapeutics made up 0.08% of Chicago Trust's portfolio in Q2 2026, its #226 holding.
  • Chicago Trust first reported a position in United Therapeutics in Q3 2024 and has held it in 6 quarters since.
  • Chicago Trust's United Therapeutics position peaked at $642K in Q1 2026.
  • 107 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Chicago Trust's 13F filing for Q2 2026, filed 16 Jul 2026.